EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Proximity-Induced Pharmacology for Amyloid-Related Diseases

Andrea Bertran-Mostazo iD, Gabrielė Putriūtė, Irene Álvarez-Berbel, Maria Antònia Busquets iD, Carles Galdeano iD, Alba Espargaró iD, Raimon Sabate iD

Cells · 04.03.2024 · 13 (5) · 449

DOI: 10.3390/cells13050449 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 04.03.2024. Verfasst von Andrea Bertran-Mostazo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, School of Pharmacy, University of Barcelona, 08028 Barcelona, Spain. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloidosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proximity-induced pharmacology (PIP) for amyloid-related diseases is a cutting-edge approach to treating conditions such as Alzheimer’s disease and other forms of dementia. By bringing small molecules close to amyloid-related proteins, these molecules can induce a plethora of effects that can break down pathogenic proteins and reduce the buildup of plaques. One of the most promising aspects of this drug discovery modality is that it can be used to target specific types of amyloid proteins, such as the beta-amyloid protein that is commonly associated with Alzheimer’s disease. This level of specificity could allow for more targeted and effective treatments. With ongoing research and development, it is hoped that these treatments can be refined and optimized to provide even greater benefits to patients. As our understanding of the underlying mechanisms of these diseases continues to grow, proximity-induced pharmacology treatments may become an increasingly important tool in the fight against dementia and other related conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloidosisHumansAmyloid beta-PeptidesPlaque, Amyloid

Stichwörter der Autor:innen

PROTACsamyloid-related diseasesconformational diseasesdrug discoveryneurodegenerative diseasesproximity-induced pharmacology

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, School of Pharmacy, University of Barcelona, 08028 Barcelona, Spain.
  • Institute of Biomedicine (IBUB), University of Barcelona, 08028 Barcelona, Spain.
  • Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain.

ORCID-Profile: Andrea Bertran-Mostazo, Maria Antònia Busquets, Carles Galdeano, Alba Espargaró, Raimon Sabate

Förderung

  • Ministerio de Ciencia e Innovación

Zitieren

APA

Bertran-Mostazo, A., Putriūtė, G., Álvarez-Berbel, I., Busquets, M. A., Galdeano, C., Espargaró, A., & Sabate, R. (2024). Proximity-Induced Pharmacology for Amyloid-Related Diseases. Cells, 13(5), 449. https://doi.org/10.3390/cells13050449

Vancouver

Bertran-Mostazo A, Putriūtė G, Álvarez-Berbel I, Busquets MA, Galdeano C, Espargaró A, et al. Proximity-Induced Pharmacology for Amyloid-Related Diseases. Cells. 2024;13(5):449. doi:10.3390/cells13050449

BibTeX
@article{BertranMostazo2024,
  author = {Bertran-Mostazo, Andrea and Putriūtė, Gabrielė and Álvarez-Berbel, Irene and Busquets, Maria Antònia and Galdeano, Carles and Espargaró, Alba and Sabate, Raimon},
  title = {Proximity-Induced Pharmacology for Amyloid-Related Diseases},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {5},
  pages = {449},
  doi = {10.3390/cells13050449}
}
Kostenlos starten →